SBI-810, identified by its CAS number 1849603-79-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular structure, solubility, and reactivity may vary, compounds like SBI-810 are typically evaluated for their biological activity, pharmacokinetics, and safety profiles. It is essential to consider its mechanism of action, which may involve interactions with specific biological targets, potentially influencing pathways relevant to disease states. Additionally, the compound's stability, shelf life, and formulation are critical for its practical use in research or clinical settings. As with many novel compounds, ongoing studies are likely to provide further insights into its efficacy and safety, contributing to a better understanding of its role in drug development. For precise details regarding its characteristics, including empirical formula and specific applications, consulting scientific literature or databases would be necessary.

SBI-810

1849603-79-7: SBI-810, identified by its CAS number 1849603-79-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular structure, solubility, and reactivity may vary, compounds like SBI-810 are typically evaluated for their biological activity, pharmacokinetics, and safety profiles. It is essential to consider its mechanism of action, which may involve interactions with specific biological targets, potentially influencing pathways relevant to disease states. Additionally, the compound's stability, shelf life, and formulation are critical for its practical use in research or clinical settings. As with many novel compounds, ongoing studies are likely to provide further insights into its efficacy and safety, contributing to a better understanding of its role in drug development. For precise details regarding its characteristics, including empirical formula and specific applications, consulting scientific literature or databases would be necessary.

<p>SBI-810 is a functional selective β-arrestin-biased allosteric modulator of the neurotensin receptor 1 (NTSR1). In the presence of the endogenous ligand neurotensin (NT), SBI-810 regulates NTSR1 signaling through a G protein-specific mechanism. It fully antagonizes NT-induced Gq activation and partially antagonizes NT-induced Gi1 activation, allowing NTSR1 to activate GoA and G12.</p>

CAS 1849603-79-7

SBI-810

SBI-810

Ref: TM-T203513